February 24, 2022

Company Name:

HEALIOS K.K.

Representative:

Hardy TS Kagimoto, Chairman & CEO

(TSE Mothers Code: 4593)

Contact:

Richard Kincaid, Executive Officer CFO

(TEL: 03-5962-9440)

Notice Concerning Reduction of Capital Stock and Capital Reserves

and Appropriation of Surplus

HEALIOS K.K. ("Healios") announces that its Board of Directors, at a meeting held on February 24, 2022, resolved to propose an agenda "Reduction of Capital Stock and Capital Reserves and Appropriation of Surplus" at the 11th General Shareholders Meeting to be held on March 25, 2022 as follows.

1. Purpose of reduction of capital stock and capital reserves and appropriation of surplus

In accordance with Article 447, paragraph 1 of the Companies Act and Article 448, Paragraph 1 of the Companies Act, we would like to reduce capital stock and capital reserves, to transfer them to other capital surplus, and then to transfer other capital surplus after the increase to retained earnings under Article 452 of the Companies Act for the purpose of eliminating carry-forward losses and reducing tax burden as per the below.

Note that this proposal does not change the number of outstanding shares and will only reduce the amount of capital stock and capital reserves, so it will not affect the number of shares held by shareholders. In addition, since there is no change in the net asset value of Healios, there is no change in the net asset value per share.

2. Details of reduction of capital stock

(1) Amount of capital stock to be reduced

2,736,468,729 yen as of December 31, 2021 out of 6,178,692,870 yen for the total amount of capital stock, to be reduced to 3,442,224,141 yen.

If the stock options issued by Healios are exercised by the effective date, the amount of the capital

1

and the amount of the capital after the decrease will fluctuate.

(2) Method to reduce capital stock

The amount of capital stock will be reduced and transferred to other capital surplus.

3. Details of reduction of capital reserves

(1) Amount of capital reserves to be reduced

2,736,468,729 yen as of December 31, 2021 out of 6,177,692,871 yen for the total amount of capital reserves, to be reduced to 3,441,224,142 yen.

If the stock options issued by Healios are exercised by the effective date, the amount of the capital reserves and the amount of the capital reserves after the decrease will fluctuate.

(2) Method to reduce capital reserves

The amount of capital reserves will be reduced and transferred to other capital surplus.

4. Details of appropriation of surplus

In accordance with the Article 452 of the Companies Act, Healios will cover the deficiency by transferring other capital surplus to retained earnings, subject to the effect of the reduction in the amount of capital stock and capital reserves as described above. As a result, the amount of retained earnings after the transfer will be 0 yen.

  1. Other capital surplus to be reduced and the amount thereof Other capital surplus 5,472,937,458 yen
  2. Retained earnings to be increased and the amount thereof Retained earnings 5,472,937,458 yen

5. Dates (planned)

(1) Date of resolution of the Board of Directors

February 24, 2022

(2) Resolution date of the General Meeting of

March 25, 2022

Shareholders

(3) Final description date of creditor's objection

March 25, 2022

(4) Effective date of reduction in capital stock,

March 31, 2022

capital reserves and appropriation of

surplus

6. Future outlook

The reduction of capital stock and capital reserves and the appropriation of surplus mentioned above are merely transfers of account titles within the net assets section, and there is no change

2

of the amount of Healios's net assets and there is no effect on Healios's business performance.

3

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Healios KK published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2022 06:11:08 UTC.